Neuroblastoma Diagnostics Driven by Artificial Intelligence
A study on neuroblastoma with bone or bone marrow metastasis (NB-BBM) used deep learning to uncover biomarkers.
Read MorePosted by Chris Wolski | Mar 11, 2025 | Unknown Origin & Other Cancer Types |
A study on neuroblastoma with bone or bone marrow metastasis (NB-BBM) used deep learning to uncover biomarkers.
Read MorePosted by Chris Wolski | Nov 18, 2024 | Lab Automation |
Artificial Intelligence enables development of new diagnostic and prognostic models, supporting the move toward personalized medicine.
Read MorePosted by Chris Wolski | Oct 14, 2024 | Cervical (HPV) |
Labcorp’s adoption of artificial intelligence technology aims to enhance the screening process for cervical cancer.
Read MorePosted by Andy Lundin | Sep 4, 2024 | Cancer, Histology |
A new AI model is capable of diagnosing multiple types of cancer, predicting patient survival, and identifying tumor molecular profiles.
Read MorePosted by Chris Wolski | May 14, 2024 | Controls |
The company has achieved a level of precision and accuracy with the artificial intelligence algorithm for use with patients.
Read More